Erythrocyte precursor cell/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{TOC|right}} | {{TOC|right}} | ||
==Parent topics== | ==Parent topics== | ||
{{r| | {{r|Hematopoiesis}} | ||
{{r|Bone marrow}} | {{r|Bone marrow}} | ||
{{r|Erythrocyte}} | {{r|Erythrocyte}} | ||
{{r| | {{r|Erythropoiesis||**}} | ||
==Subtopics== | ==Subtopics== | ||
{{r|Megaloblast}} | {{r|Megaloblast}} | ||
==Other related topics== | ==Other related topics== | ||
{{Human iron metabolism}} | {{r|Erythropoietin}} | ||
{{r|Human iron metabolism}} | |||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Myelodysplastic syndrome}} | |||
Latest revision as of 16:00, 13 August 2024
- See also changes related to Erythrocyte precursor cell, or pages that link to Erythrocyte precursor cell or to this page or whose text contains "Erythrocyte precursor cell".
Parent topics
- Hematopoiesis [r]: The processes by which all types of blood cells are generated, in the bone marrow, from pluripotential stem cells that differentiate into normal or abnormal circulating elements of blood [e]
- Bone marrow [r]: The soft tissue, inside the hollow cavities of bones, which produces blood cells [e]
- Erythrocyte [r]: Blood cells that carry hemoglobin [e]
Subtopics
- Megaloblast [r]: An abnormally large (i.e., macrocytic) erythroblast; as with macrocytic erythrocytes, they are associated with folic acid or vitamin B12 deficiency or metabolic disorder [e]
- Erythropoietin [r]: A protein hormone produced by the kidneys in response to hypoxia; it is essential for normal development and maturation of red blood cells (RBC). [e]
- Human iron metabolism [r]: Mechanisms of ingestion, distribution, use and excretion of iron by the human body, as well as an introduction to disorders of iron metabolism [e]
- Myelodysplastic syndrome [r]: Haematological conditions united by ineffective production of blood cells and varying risks of transformation to acute myelogenous leukaemia. [e]